- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05820243
Determinants of Changes in Arterial Load Following Exercise
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
During exercise, blood vessels increase in size to supply muscles with more blood. After exercise, the muscles that had been used release chemicals called histamines that cause the blood vessels to stay dilated even when the muscles no longer need more blood. It takes around 2 hours for the blood vessels to return to normal. This causes blood pressure to be lower than it usually is at rest. This phenomenon delays the return of pressure waves in arteries that are reflected back to the heart resulting in the heart having to work less hard to pump out blood for about 2 hours after exercise. However, it is unknown why the reflected pressure waves return to the heart later. The aim of this study is to determine if this delay is due to the speed of the reflected waves being slowed by large arteries or dilation of small arteries resulting in the reflections originating further from the heart. By giving antihistamines prior to exercise, post-exercise blood vessel dilation of the small arteries will be largely reduced, thus allowing for the determination of which factor causes the reflected waves to return later. Additionally, it is hypothesized that the reduction in work that the heart must perform results in improved contraction and relaxation of the heart. Thus, an additional aim is to determine how post-exercise blood vessel dilation influence heart function.
To accomplish these aims, blood flow leaving the left ventricle and femoral blood flow will be measured via Doppler ultrasound. Applanation tonometry will be used to record pulse waves at the carotid, radial, femoral, and dorsalis pedis arteries. These pulse waves will be used to estimate central blood pressure and to determine pulse wave velocity of different arterial segments. Measurements will be made at baseline and for 120 minutes after a bout of moderate intensity aerobic exercise.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: David Edwards, PhD
- Phone Number: 302-831-3363
- Email: dge@udel.edu
Study Contact Backup
- Name: Jordan Patik, PhD
- Phone Number: 5128206387
- Email: jpatik@udel.edu
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Recruiting
- Department of Kinesiology and Applied Physiology, University of Delaware
-
Contact:
- David Edwards, PhD
- Email: dge@udel.edu
-
Principal Investigator:
- David Edwards, PhD
-
Contact:
- Jordan Patik, PhD
- Email: jpatik@udel.edu
-
Principal Investigator:
- Jordan Patik, PhD
-
Sub-Investigator:
- Zoe Lincoln, BS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- healthy men and women
- sedentary or recreationally active
Exclusion Criteria:
- history of cardiovascular events or procedures
- stage 2 hypertension (BP: ≥140 systolic or ≥90 diastolic)
- metabolic syndrome
- renal disease
- chronic respiratory disease
- currently prescribed any cardiovascular medication
- current use of erythromycin and/ ketoconazole
- current pregnancy or breastfeeding -hormone replacement therapy-
- tobacco use
- musculoskeletal injury/disorder that would inhibit cycling exercise
- body mass index (BMI) <18.5 or >35kg/m^2
- reduced kidney function (estimated glomerular filtration rate< 90ml/min/1.73 m^2)
- daily use of fexofenadine and/or famotidine
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Antihistamine
The oral antihistamine condition will consist of fexofenadine (540mg) and famotidine (40mg).
Commercially available pills (3 x 180mg fexofenadine and 2 x 20mg famotidine) will be placed within opaque capsules and administered to the participants upon arrival to the laboratory.
|
Participants will complete 1 hour of exercise on a cycle ergometer at the power output that elicits 60% of their peak rate of oxygen consumption (V02peak).
|
|
Placebo Comparator: Placebo
The placebo condition will consist of dextrose in an identical number of opaque capsules as the antihistamine treatment.
Total dextrose will be <5g.
The capsules will be administered to the participants upon arrival to the laboratory.
|
Participants will complete 1 hour of exercise on a cycle ergometer at the power output that elicits 60% of their peak rate of oxygen consumption (V02peak).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in lower limb arterial stiffness
Time Frame: 120 minutes post-exercise
|
Arterial stiffness of the leg will be assessed via measurement of femoral-pedis pulse wave velocity.
|
120 minutes post-exercise
|
|
Change in leg vascular conductance
Time Frame: 120 minutes post-exercise
|
Vascular conductance, an index of peripheral vasodilation, will be determined by measuring femoral blood flow via ultrasound and dividing by mean arterial pressure.
|
120 minutes post-exercise
|
|
Change in left ventricular pulsatile load
Time Frame: 120 post-exercise
|
Doppler echocardiography and arterial tonometry will be used to establish left ventricular pressure-flow relations.
Wave separation analysis will subsequently be performed to determine the magnitude and timing of reflected pulse waves.
|
120 post-exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in left ventricular diastolic function
Time Frame: 120 minutes post-exercise
|
Echocardiographic measures of left ventricular diastolic function will be recorded, including mitral annulus tissue velocity and mitral in-flow velocity
|
120 minutes post-exercise
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1783804
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Exercise Hypotension
-
California Baptist UniversityCompletedPrehypertension (elevated Blood Pressure) or HypertensionUnited States
-
Federal University of Rio Grande do SulCompletedControl Session (CON) | Dynamic Strength Exercise Session | Isometric Strength Exercise Session | Combined Exercise Session | Dynamic Strength Training | Combined Strength Training | Isometric Strength TrainingBrazil
-
Universidade Federal de Santa CatarinaCompleted
-
Instituto de Cardiologia do Rio Grande do SulCompleted
-
University of ConnecticutHartford HospitalCompletedHypertension
-
University of GuelphCompletedPost-Exercise Hypotension | Ambulatory Blood Pressure Monitoring | High-intensity Interval ExerciseCanada
-
University of OregonActive, not recruitingPostexercise HypotensionUnited States
-
Universidade Federal do vale do São FranciscoCompletedPost-Exercise Hypotension
-
Arizona State UniversityTerminated
-
University of ConnecticutHartford HospitalCompletedCardiovascular Diseases | Post-Exercise HypotensionUnited States
Clinical Trials on Moderate Intensity Aerobic Exercise
-
Marquette UniversityRecruitingQuality of Life | Pain | Aging | Pain Management | Exercise Training | Aerobic Exercise | Sports | Athlete | Strength Training | Sports Medicine | Strength Training EffectsUnited States
-
Riphah International UniversityCompletedHeart DiseasesPakistan
-
University of North Carolina, GreensboroRecruitingCognitive Change | Aerobic ExerciseUnited States
-
University of MichiganCompletedWeight Loss | Aerobic Exercise | Obesity & Overweight | Ramadan FastingUnited States
-
Universidad Francisco de VitoriaNot yet recruitingBreast Cancer | Radiotherapy | Physical Fitness | Immune System | Inflamation
-
Cairo UniversityCompleted
-
Malatya Turgut Ozal UniversityCompletedSleep Disturbance | Post-Traumatic Stress DisorderTurkey (Türkiye)
-
University of PittsburghNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
University of SharjahCompletedMultiple Sclerosis | Urinary IncontinenceJordan
-
Deraya UniversityCompleted